(a): whether the Government has received representations from small scale pharma units;
(b): if so, the details thereof; and
(c): the steps taken to protect the survival of genuine small scale pharma units?
(a): whether the Government has received representations from small scale pharma units;
(b): if so, the details thereof; and
(c): the steps taken to protect the survival of genuine small scale pharma units?
MINISTER OF SMALL SCALE INDUSTRIES & AGRO AND RURAL INDUSTRIES ( SHRI MAHABIR PRASAD )
(a): Yes, Sir.
(b): Representations have been received from several small scale
pharma units and associations regarding -
(i) difficulties faced by them in implementing the revised
Schedule-M to the Drugs & Cosmetics Rules,1945 and seeking
extension of time for implementation threof and also for
reconsideration of the norms;
(ii) Ministry of Finance, Department of Revenue notification No.
2/2005-Central Excise(N.T.)dated 7.1.2005 subjecting drugs to
maximum retail price (MRP) based levy of Central excise duty with
35 per cent abatement.
(c): The following steps have been taken in this context -
(i) Considering the representations, the Government of India in
the Ministry of Health and Family Welfare has extended the date of
implementation of revised Schedule-M relating to Good
Manufacturing Practices (GMP) from 31.12.03 to 30.06.05 under
notification No. H-11014/7/2003-DMS & PFA dated 4/6 January, 2005.
(ii) Financial assistance for technology upgradation is available
to small scale pharma units under the Credit Linked Capital
Subsidy Scheme of the Central Government, Ministry of Small Scale
Industries.
(iii) The Central Government has increased the abatement rate for
levy of MRP based central excise duty on drugs from 35 percent to
40 percent of MRP under notification No. 4/2005-Central
Excise(N.T.) dated 23rd February, 2005.